Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells

Yasushi Takenouchi1, Myat Lin Oo, Takeshi Senga

  • 1Division of Cancer Biology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan.

Oncology Reports
|April 8, 2004
PubMed

Insights

Active Src kinases phosphorylate endothelial nitric oxide synthase (NOS3) in human breast cancer cells. This phosphorylation is dependent on Src activity and its membrane-bound form, suggesting a role in cancer progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Endothelial nitric oxide synthase (NOS3) plays a role in various cellular processes.
  • Src kinases are known to regulate cellular signaling pathways, including those implicated in cancer.

Purpose of the Study:

  • To investigate the role of active Src in the tyrosine phosphorylation of NOS3.
  • To determine the specific forms of Src that mediate NOS3 phosphorylation.

Main Methods:

  • Utilized human breast cancer cell line (BT474).
  • Employed Src kinase inhibitors (PP1) and various Src mutants (v-Src, c-Src, Y527F, G2A, K295M).
  • Analyzed NOS3 phosphorylation levels via Western blotting and kinase activity assays.

Main Results:

  • Confirmed activation of c-Src and NOS3 tyrosine phosphorylation in BT474 cells.
  • Demonstrated dose-dependent suppression of NOS3 phosphorylation by PP1, indicating Src kinase involvement.
  • Observed significant NOS3 phosphorylation with v-Src and Y527Fc-Src, but not with c-Src, G2Av-Src, or K295Mv-Src.
  • Showed temperature-dependent NOS3 phosphorylation with a temperature-sensitive v-Src mutant.

Conclusions:

  • Active, membrane-bound Src kinases induce constitutive tyrosine phosphorylation of NOS3.
  • Specific Src forms and kinase activity are critical for NOS3 phosphorylation.
  • Findings suggest a potential mechanism linking Src activity to NOS3 regulation in breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...